S eizureS are the presenting sign of disease in 83% of patients diagnosed with low-grade glioma (LGG), and contribute to poor quality of life. 15, 23, 24 In the disease course of LGGs, 60%-85% of patients present with seizure, and a change in seizure-onset features has proven to be an important sign of tumor progression.
outcome. 11 More aggressive resections, while preserving normal eloquent areas, have been shown to improve seizure freedom. 9 Moreover, seizure control has been reported to be achieved in more than 76% of patients after insular glioma surgery accompanied by perilesional cortical resection. 8 Unfortunately, because most LGGs grow close to or within eloquent areas, aggressive resection can be achieved in no more than 45%. 2, 10 Hippocampectomy and corticectomy combined with lesionectomy in patients with LGGs and intractable seizures have been shown to improve seizure control. 12, 21 However, using intraoperative electrocorticography (ECoG) to identify epileptogenic areas, guide surgical strategy, and improve postoperative seizure control in patients with LGGs remains inconclusive.
Seizure control is one of the most important considerations in planning a surgical strategy for LGGs. In this retrospective study, we investigated the predictors of postoperative seizure outcome, including intraoperative ECoG, preoperative seizure history, histological tumor subtype, and others. Furthermore, the epileptogenic areas of different locations of LGGs will be analyzed, and the impact of epilepsy areas resected for seizure control will be evaluated.
Methods

Patient Population
We retrospectively analyzed the medical records of 108 adult patients with LGGs (located at the frontal, temporal, or parietal lobes) presenting with refractory seizures who underwent surgery at our institute between January 2002 and March 2015. In all patients, seizure was the initial symptom. Two experienced independent neurophysiologists (F.W. and S.F.Z.) reviewed the preoperative and intraoperative electroencephalography (EEG) recordings. Patients were divided into 2 groups. In Group I, all patients underwent GTR combined with resection of epileptic areas guided by intraoperative ECoG, while patients in Group II underwent only GTR. Patients without complete resection of tumor were excluded. Intraoperative neuronavigation was used to evaluate the tumor location and extent of resection. In addition, complete resection of tumor was evaluated by postoperative MRI findings (within 72 hours). Patients without GTR were excluded.
Data Collection
Data on tumor location, tumor size, seizure-onset feature, seizure frequency, seizure duration, pre-and postoperative MRI findings, intraoperative electrophysiological monitoring, and postoperative Engel class were collected. Histological type was determined according to the WHO brain tumor classification.
All patients were evaluated every 3 months postoperatively until 12 months using the Engel classification of seizures: 19 1) Class I, completely seizure-free, auras only or only atypical early postoperative seizures; 2) Class II, ≥ 50% seizure reduction or nocturnal seizures only; 3) Class III, < 50% seizure reduction; and 4) Class IV, no seizure reduction or deterioration. Engel class at 12 months was used to compute predictors of postoperative seizure outcome.
The study protocol was approved by the ethics committee of First Affiliated Hospital of Fujian Medical University. All patients provided written informed consent.
Surgical Strategy and Intraoperative ECoG
The anesthesiology protocol has been previously described. 16 Awake craniotomy was not performed in the study. All patients underwent a preoperative EEG examination according to the 10-20 International System. Intraoperative ECoG was used in the patients of Group I as previously described. 7 An epileptic EEG pattern was characterized by a background of alpha waves mixed with slower activity or alpha waves with faster rhythms. In Group I, epileptic areas were removed completely before closing the dura mater. Intraoperative motor evoked potentials and somatosensory evoked potentials were used to monitor the integrity of motor and somatosensory function. The anterior part of the temporal lobe was defined as a maximum of 6.0 cm of the anterior lateral nondominant temporal lobe and 4.0-4.5 cm of the dominant temporal lobe. 28 For ECoG monitoring, multi-electrode silicon strips (24 or 32 electrodes) with an intercontact distance of 10 mm were placed on the lesional tissue and surroundings. ECoG was recorded during a pre-resection phase, the end of the tumor resection phase, and the end of the epileptic area resection. The low-frequency filter was set at 1 Hz, the high-frequency filter was set at 50 Hz, and the gain was between 200 mV and 400 mV, depending on the amplitude of the background and discharges.
Statistical Analysis
Measurement data were expressed as mean ± SD. An ANOVA or Student t-test was used to assess the statistical differences between the 2 groups. Qualitative data were analyzed using a chi-square test or Fisher's exact test. A p value < 0.05 was considered statistically significant. Multivariate logistic regression analyses included all variables significant at p < 0.15 in univariate analysis. For inclusion in the multivariate model, histological tumor subtype was dichotomized as "oligodendroglioma" or "non-oligodendroglioma," tumor location as "temporal" or "non-temporal," postoperative Engel class as "favorable outcome" (Engel Class I or II) or "unfavorable outcome" (Engel Class III or IV). Results are presented as odds ratios (ORs) and 95% confidence intervals (CIs).
Results
The records from 108 patients (64 males and 44 females) were collected between January 2002 and March 2015 in this prospective study. There were a total of 108 LGGs undergoing GTR. In Group II, 54 patients (30 males, 24 females, average age 25.4 ± 14.8 years) underwent GTR, while 54 patients (34 males, 20 females, average age 27.0 ± 14.2 years) in Group I underwent GTR combined with resection of epileptic areas guided by intraoperative ECoG monitoring. The clinical characteristics of the 2 groups are shown in Table 1 . In all cases, preoperative MRI showed a lesion with hypointensity on T1-weighted MRI sequences and hyperintensity on T2-weighted MRI sequences with and without contrast medium. Preoperative neurological function was normal in all patients. All patients presented with seizure as the onset symptom.
Postoperative seizure control was similar every 3 months. At the 12-month follow-up evaluations, the majority of patients had received some benefit with respect to seizure control. Univariate analysis demonstrated that tumor location and intraoperative ECoG monitoring correlated with seizure outcome. To explore the actual risk factors, the variables that were marginally significant at univariate analysis (p < 0.15) were entered into a multivariate logistic regression model. In the final model, ECoG monitoring was shown to be the only variable that significantly influenced the outcome. Postoperative seizure control was improved by intraoperative ECoG monitoring (OR 0.089, 95% CI 0.019-0.411, p = 0.002). In addition, we divided the 2 groups into temporal lobe location versus other locations, and found that tumor location was not significantly associated with seizure outcome in Group I ( Table 2) .
There were 30 temporal lobe tumors, 22 frontal lobe tumors, and 2 parietal lobe tumors in Group I, with 18, 24, and 12 in Group II (p < 0.05; Table 1 ). In Group I, 74.07% of patients were completely seizure free (Engel Class I), whereas 38.89% were Engel Class I in Group II (p < 0.05). Overall, in Group I, 96.30% of patients achieved satisfactory postoperative seizure control (Engel Class I or II), compared with 77.78% in Group II (p < 0.05). There were 2 patients with no improvement in postoperative seizures (Engel Class IV) in Group I, and postoperative MRI displayed infarction in 1 patient (Table 1 ). In Group I it was shown that intraoperative ECoG monitoring significantly improved seizure control (p < 0.05, Table 1 ). However, univariate analysis indicated the difference in seizure control between the 2 groups was also influenced by tumor location (p < 0.05, Table 1 ).
Intraoperative ECoG monitoring indicated that in patients with temporal lobe tumors, most of the epileptic discharges were detected at the anterior part of the temporal lobe (86.7%), while only 13.3% were detected at the medial and posterior part of the temporal lobe (Table 3) . In these patients with epileptic discharges at the anterior part of the temporal lobe, satisfactory postoperative seizure control (93.3%, Engel Class I and II) was achieved after resection of the anterior part of the temporal lobe (Tables 1 and 2 ). Interestingly, in 20% of patients with temporal lobe tumors, epileptic discharges were found at both the temporal and frontal lobes. And after resection of tumor and epileptic areas of the temporal lobe, epileptic discharges were not detected at both temporal and frontal lobes (Table 3 ). However, in the patients with frontal lobe tumors, most of the epileptic discharges were found at the peritumoral tissues (63.6%, Table 3 ). In these patients with peritumoral abnormal discharges, epileptic discharges were found at both the temporal and frontal lobes in 9.1% of patients. However, after resection of tumor and epileptic areas of the frontal lobe, epileptic discharges of the tem- poral lobe were not detected. In the patients with parietal lobe tumors, peritumoral epileptic discharges were found accompanied by frontal and temporal epileptic discharges. Resection of tumor and epileptic areas was beneficial for seizure control in patients with parietal lobe tumors. There were 16 gangliogliomas located at the temporal lobe, and 2 at the frontal lobe. The majority of the patients with gangliogliomas (88.89%) had a favorable outcome after complete resection of tumor (Table 4 ). Seizure control according to different postoperative pathologies is shown in Table 4 , and seizure control according to different tumor locations is shown in Table 3 .
Discussion
Seizure control has been proven to be associated with tumor progression and overall survival, especially in
LGGs. Following glioma resection, patients with LGGs and perioperative seizures experienced shorter overall survival. 6 In the surgery of LGGs, seizure control is one of the most important considerations in planning surgical strategy.
More aggressive resections of LGGs and perilesional cortical resections have been shown to improve overall survival and seizure freedom. 8, 9 Unfortunately, because most LGGs grow close to eloquent areas, aggressive resection of tumor and surrounding areas could not be achieved in most patients with LGGs. 2, 10 More importantly, previous studies indicated that it is dangerous to remove mesial structures of the temporal lobe because of severe postoperative memory problems. 13 Hippocampectomy and corticectomy combined with lesionectomy in paralimbic Grade II gliomas with intractable seizures has been shown to improve seizure control. 12, 21 However, epileptogenic areas in patients with nonparalimbic LGGs remain unknown. In this study we found that intraoperative ECoG monitoring provides the exact location of epileptogenic areas and significantly improves seizure control of LGGs, and the result was influenced by tumor location. Tumor location was shown to be associated with seizure control in the study (p < 0.05, Table 1 ). 26, 27 In the patients with temporal lobe tumors, most of the epileptic discharges were detected at the anterior part of the temporal lobe (86.7%). In these patients, satisfactory postoperative seizure control (93.3%, Engel Class I and II) was achieved after resection of the anterior part of the temporal lobe (Tables 1-3 ). We suggest that in LGGs with epileptic discharges at the anterior part of the temporal lobe, resection of tumor and the anterior part of the temporal lobe is sufficient for seizure control. Interestingly, in 20% of patients with temporal lobe tumors, epileptic discharges were found at both the temporal and frontal lobes. After resection of tumor and epileptic areas of the temporal lobe, epileptic discharges of the frontal lobe were not detected. Previous studies indicated that an extended lesionectomy including the adjacent cortical dysplasia was necessary to achieve a seizure-free outcome in patients with temporal gliomas. 20 However, we found that resection of the anterior temporal lobe with epileptic discharges was sufficient, even if the epileptic discharges could be found at both the temporal and frontal lobes. Kemerdere et al. indicated that in the patients with temporal lobe LGGs, lesionectomy involving an anterior temporal lobe resection accompanied by a hippocampectomy demonstrated improved seizure outcome and a decrease in the chance of a tumor upgrade. 17 In patients with temporal lobe LGGs, no perilesional epileptic discharge was found in any of the patients. In this study, approximately 8% of the patients with temporal lobe LGGs presented with medial and posterior epileptic discharges, and resection of the medial temporal lobe would be safe and improve postoperative seizure control.
However, in the patients with frontal lobe tumors, most of the epileptic discharges were at the peritumoral tissues (63.6%). In these patients, epileptic discharge was found at both the temporal and frontal lobes in 9.1% of patients. Based on the complete resection of LGGs, the epileptic areas should also be resected, especially in the anterior and medial parts of the frontal lobe. If the epileptic areas are located close to the motor and sensory pathways, postoperative AEDs should be given. In the patients with parietal lobe tumors, peritumoral epileptic areas should be resected as well as LGGs located at the frontal lobe. Peritumoral epileptic area resection was as similar as aggressive resection of LGGs and has been shown to improve seizure control and overall survival. Histological tumor subtype is associated with postoperative seizure control. 25 Oligoastrocytomas and oligodendrogliomas more often are located at the cortex and more frequently present with seizures compared with astrocytomas, which tend to involve the white matter. 5 Resection of astrocytomas without intraoperative ECoG monitoring is more prone to suffer from an unfavorable outcome of seizure control in the study (Table 4) . However, most of the patients with gangliogliomas have a favorable outcome after complete resection of tumor. Previous studies indicated that rates of postoperative seizure freedom ranged from 63% to 100% 3 in patients with gangliogliomas. The majority of gangliogliomas (85.7%) in this study were found at the temporal lobe, similar to previous studies (Table 4) . 3 Previous studies indicate that poor seizure control was more frequent in patients with a longer duration of seizure history and higher frequency of seizures. 15 The absence of generalized seizures was also associated with favorable postoperative outcome. 1 However, we did not find that seizure-onset features, seizure frequency, seizure duration, or preoperative AED therapy were associated with postoperative seizure control.
Limitations of the Study
Intraoperative ECoG monitoring significantly improved seizure freedom in this study. However, the result was influenced by different tumor locations. A larger sample or a randomized study is needed to verify our findings. In addition, although ECoG electrodes implanted on the surface of the brain could reach better signal quality at a higher frequency and have significantly higher spectral amplitudes than epidural contacts, subdural ECoG electrodes are more invasive and have the potential impact of a surgical site infection. 4 In the future, epidural electrodes should also be used. The hippocampus plays an important part in the seizures of patients without LGGs, whereas the role of the hippocampus in the seizures of patients with
LGGs remains unknown. To explore the relation between the hippocampus and seizure control in patients with
LGGs, further intraoperative recordings of hippocampal activity should be conducted.
Conclusions
Intraoperative ECoG monitoring provided the exact location of epileptogenic areas and significantly improved the postoperative seizure control of LGGs in this study. In patients with temporal lobe LGGs, resection of the anterior temporal lobe with epileptic discharges was sufficient, even when the epileptic discharges could be found at both the temporal and frontal lobes.
